Quality assurance of the EORTC 26981/22981; NCIC CE3 intergroup trial on radiotherapy with or without temozolomide for newly-diagnosed glioblastoma multiforme: the individual case review

476 Quality assurance report of EORTC 26981/22981 trial on radiotherapy vs radiotherapy and temozolomide for newly diagnosed glioblastoma multiforme: individual case review

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(03)90508-8 ◽

2003 ◽

Vol 1 (5) ◽

pp. S145

Author(s):

F. Ataman ◽

P. Poortmans ◽

R. Stupp ◽

R.O. Mirimanoff

Keyword(s):

Quality Assurance ◽

Glioblastoma Multiforme ◽

Individual Case ◽

Newly Diagnosed ◽

Case Review ◽

Radiotherapy quality assurance for the RTOG 0834/EORTC 26053-22054/NCIC CTG CEC.1/CATNON intergroup trial “concurrent and adjuvant temozolomide chemotherapy in newly diagnosed non-1p/19q deleted anaplastic glioma”: Individual case review analysis

Radiotherapy and Oncology ◽

10.1016/j.radonc.2018.03.013 ◽

2018 ◽

Vol 127 (2) ◽

pp. 292-298 ◽

Cited By ~ 5

Author(s):

André N. Abrunhosa-Branquinho ◽

Raquel Bar-Deroma ◽

Sandra Collette ◽

Enrico Clementel ◽

Yan Liu ◽

...

Keyword(s):

Quality Assurance ◽

Individual Case ◽

Anaplastic Glioma ◽

Newly Diagnosed ◽

Case Review ◽

Review Analysis ◽

Adjuvant Temozolomide ◽

Intergroup Trial ◽

Temozolomide Chemotherapy

999 poster Quality assurance in the EORTC trial 22991: the individual case review

Radiotherapy and Oncology ◽

10.1016/s0167-8140(04)82866-4 ◽

2004 ◽

Vol 73 ◽

pp. S421

Keyword(s):

Quality Assurance ◽

Individual Case ◽

Case Review ◽

Quality assurance of EORTC trial 22922/10925 investigating the role of internal mammary—medial supraclavicular irradiation in stage I-III breast cancer: the individual case review

European Journal of Cancer ◽

10.1016/s0959-8049(03)00455-6 ◽

2003 ◽

Vol 39 (14) ◽

pp. 2035-2042 ◽

Cited By ~ 39

Author(s):

P. Poortmans ◽

V.E. Kouloulias ◽

J.L. Venselaar ◽

H. Struikmans ◽

J.B. Davis ◽

...

Keyword(s):

Breast Cancer ◽

Quality Assurance ◽

Individual Case ◽

Stage I ◽

Case Review ◽

Internal Mammary ◽

The Individual ◽

Medial Supraclavicular

476 Poster Quality assurance of the EORTC trial 22921 concerning pre-operative radiotherapy with or without chemotherapy for resectable rectal cancer: evaluation of the individual case review procedure

Radiotherapy and Oncology ◽

10.1016/s0167-8140(02)82788-8 ◽

2002 ◽

Vol 64 ◽

pp. S154

Keyword(s):

Rectal Cancer ◽

Quality Assurance ◽

Individual Case ◽

Case Review ◽

Resectable Rectal Cancer ◽

Review Procedure ◽

Quality Assurance in the Prospective Multi-institutional Trial on Definitive Radiotherapy Using High-dose-rate Intracavitary Brachytherapy for Uterine Cervical Cancer: The Individual Case Review

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyp105 ◽

2009 ◽

Vol 39 (12) ◽

pp. 813-819 ◽

Cited By ~ 3

Author(s):

Takafumi Toita ◽

Masahiko Oguchi ◽

Tatsuya Ohno ◽

Shingo Kato ◽

Yuzuru Niibe ◽

...

Keyword(s):

Cervical Cancer ◽

Quality Assurance ◽

Dose Rate ◽

Individual Case ◽

Uterine Cervical Cancer ◽

High Dose Rate ◽

Intracavitary Brachytherapy ◽

High Dose ◽

Case Review ◽

Cytotoxic chemotherapeutic management of newly diagnosed glioblastoma multiforme

Journal of Neuro-Oncology ◽

10.1007/s11060-008-9615-4 ◽

2008 ◽

Vol 89 (3) ◽

pp. 339-357 ◽

Cited By ~ 13

Author(s):

Camilo E. Fadul ◽

Patrick Y. Wen ◽

Lyndon Kim ◽

Jeffrey J. Olson

Keyword(s):

Glioblastoma Multiforme ◽

Newly Diagnosed ◽

Differentiation of Newly Diagnosed Glioblastoma Multiforme and Intracranial Diffuse Large B-cell Lymphoma Using 11C-Methionine and 18F-FDG PET

Clinical Nuclear Medicine ◽

10.1097/rlu.0b013e318262af48 ◽

2012 ◽

Vol 37 (9) ◽

pp. 843-849 ◽

Cited By ~ 20

Author(s):

Yumiko Okada ◽

Takashi Nihashi ◽

Masazumi Fujii ◽

Katsuhiko Kato ◽

Yoshiyuki Okochi ◽

...

Keyword(s):

Glioblastoma Multiforme ◽

B Cell ◽

Fdg Pet ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Newly Diagnosed ◽

Large B Cell Lymphoma ◽

Newly Diagnosed Glioblastoma ◽

18F Fdg ◽

Large B Cell

NCOG-18. PHASE I TRIAL OF DIMETHYL FUMARATE, TEMOZOLOMIDE AND RADIATION THERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME: A PRELIMINARY NEUROCOGNITIVE PERSPECTIVE

Neuro-Oncology ◽

10.1093/neuonc/nox168.579 ◽

2017 ◽

Vol 19 (suppl_6) ◽

pp. vi141-vi142

Author(s):

Ashlee Loughan ◽

Danielle Shafer ◽

Autumn Lanoye ◽

Sarah Braun ◽

Paul Dent ◽

...

Keyword(s):

Radiation Therapy ◽

Glioblastoma Multiforme ◽

Phase I ◽

Phase I Trial ◽

Dimethyl Fumarate ◽

Newly Diagnosed ◽

An American Brain Tumor Consortium (ABTC) Phase 1 Trial of Veliparib (ABT-888), Temozolomide (TMZ), and Concurrent Radiation Therapy (RT) for Newly Diagnosed Glioblastoma Multiforme (GBM): Need for Modification to Approach for Combining These Therapies

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2012.07.025 ◽

2012 ◽

Vol 84 (3) ◽

pp. S7-S8 ◽

Cited By ~ 3

Author(s):

L.R. Kleinberg ◽

J. Blakeley ◽

T. Mikkelsen ◽

G. Stevens ◽

X. Ye ◽

...

Keyword(s):

Radiation Therapy ◽

Brain Tumor ◽

Glioblastoma Multiforme ◽

Phase 1 ◽

Newly Diagnosed ◽

Phase 1 Trial ◽